Boston Scientific Corporation
Organization details
- Legal name
- Boston Scientific Corporation
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 3841 — Surgical & Medical Instruments & Apparatus
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Marlborough
- Headquarters state / province
- Massachusetts
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- BSX
- Primary stock exchange
- NYSE
Identifiers
- SEC CIK
- 0000885725
- EIN
- 04-2695240
- Wikidata ID
- Q894585
Board of directors
-
Cathy R. Smith · DirectorSince 2026
-
Charles J. Dockendorff · DirectorSince 2023
-
Cheryl Pegus · DirectorSince 2024
-
Christophe Pierre Weber · DirectorSince 2026
- Since 2024
-
David J. Roux · DirectorSince 2023
-
David S. Wichmann · DirectorSince 2023
-
Edward J. Ludwig · DirectorSince 2023
- Since 2023
-
Jessica L. Mega · DirectorSince 2023
-
John E. Sununu · DirectorSince 2023
-
Michael F. Mahoney · Director · Chairman, President & CEOSince 2023
- Since 2023
-
Susan E. Morano · DirectorSince 2023
-
Yoshiaki Fujimori · DirectorSince 2023
Chief executives
Director election results
Annual meeting of April 30, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
85.9%
-
92.3%
-
92.7%
-
95.3%
-
95.8%
-
97.1%
-
99.0%
-
99.1%
-
99.3%
-
99.8%
Board connections
12 of this board's directors also sit on 22 other boards. 5 are in the same sector.
-
Baxter International Inc. Same sectorvia Cathy R. Smith and Michael F. Mahoney
- via Edward J. Ludwig and Michael F. Mahoney
-
Haemonetics Corporation Same sectorvia Charles J. Dockendorff and Ellen M. Zane
-
Takeda Pharmaceutical Company Limited Same sectorvia Christophe Pierre Weber and Yoshiaki Fujimori
- via Ellen M. Zane
- via Nelda J. Connors
- via Yoshiaki Fujimori
- via Nelda J. Connors
-
Concentra Group Holdings Parent Inc. Same sectorvia Cheryl Pegus
- via Nelda J. Connors
- via Jessica L. Mega
- via David C. Habiger
- via Ellen M. Zane
- via Charles J. Dockendorff
- via David C. Habiger
- via Nelda J. Connors
- via Cathy R. Smith
-
Privia Health Group Inc. Same sectorvia David S. Wichmann
- via David C. Habiger
- via Ellen M. Zane
- via David C. Habiger
- via Nelda J. Connors
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $10,039,630
- 10 purchases by 5 insiders
- Sold, last 12 months
- $16,801,454
- 3 sales by 2 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 4, 2026 | Michael F. Mahoney Director, Officer (Chairman, President & CEO) | Gift | +149,992 | — | — |
| Nov 4, 2026 | Michael F. Mahoney Director, Officer (Chairman, President & CEO) | Gift | +102,249 | — | — |
| Nov 1, 2026 | O'Sullivan Miriam Officer (SVP, Chief HR Officer) | Option exercise | +3,871 | — | — |
| Nov 1, 2026 | O'Sullivan Miriam Officer (SVP, Chief HR Officer) | Shares withheld for tax | −1,872 | $41.98 | $78,587 |
| Sep 2, 2026 | O'Connor Padraig Andrew Officer (EVP, Global Operations) | Option exercise | +1,171 | — | — |
| Sep 2, 2026 | O'Connor Padraig Andrew Officer (EVP, Global Operations) | Shares withheld for tax | −567 | $48.37 | $27,426 |
| Aug 25, 2026 | Susan E. Morano Director | Open-market purchase | +2,040 | $49.22 | $100,409 |
| Aug 11, 2026 | Woodworth Emily Officer (SVP, Global Controller and CAO) | Discretionary transaction | +2,930 | $51.19 | $149,987 |
| Aug 10, 2026 | Monson Jonathan Officer (EVP and CFO) | Discretionary transaction | +9,908 | $50.46 | $499,958 |
| Aug 5, 2026 | David C. Habiger Director | Open-market purchase | +2,100 | $47.59 | $99,939 |
| Aug 4, 2026 | David C. Habiger Director | Open-market purchase | +140 | $48.59 | $6,803 |
| Aug 3, 2026 | Michael F. Mahoney Director, Officer (Chairman, President & CEO) | Open-market purchase | +186,240 | $48.33 | $9,000,979 |
| Aug 3, 2026 | David C. Habiger Director | Open-market purchase | +1,042 | $48.07 | $50,089 |
| Aug 3, 2026 | Michael F. Mahoney Director, Officer (Chairman, President & CEO) | Discretionary transaction | +22,119 | $48.43 | $1,071,223 |
| Jul 31, 2026 | Fitzgerald Joseph Michael Officer (EVP & Group Pres, Cardiology) | Discretionary transaction | +64,198 | $46.73 | $2,999,973 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Boston Scientific Corporation
Who is the CEO of Boston Scientific Corporation?
Michael F. Mahoney is Boston Scientific Corporation's Chairman, President & CEO.
How many directors are on Boston Scientific Corporation's board?
Boston Scientific Corporation's board has 15 directors: Cathy R. Smith, Charles J. Dockendorff, Cheryl Pegus, Christophe Pierre Weber, David C. Habiger, David J. Roux, David S. Wichmann, Edward J. Ludwig, Ellen M. Zane, Jessica L. Mega and 5 others.
Are Boston Scientific Corporation insiders buying or selling shares?
Over the last 12 months, Boston Scientific Corporation insiders bought $10.0 million of shares in 10 purchases and sold $16.8 million of shares in 3 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="boston-scientific-corporation"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.